Daewoong Chemical

Daewoong Chemical is a South Korean manufacturer focused on pharmaceutical raw materials, active pharmaceutical ingredients, and intermediates. The company appears to have been established in the early 1980s as a spinout of the raw-materials synthesis team from Daewoong Pharmaceutical and has operated as a commercial supplier rather than a clinical-stage drug developer. Publicly available profiles describe capabilities in API synthesis, sterile API production, quality control, and cGMP/BGMP-oriented manufacturing infrastructure. Products cited across industry directories include small-molecule APIs such as ursodeoxycholic acid, simvastatin, rebamipide, fluconazole, cilostazol, cefuroxime sodium, and related intermediates. Based on available evidence, it is best characterized as a healthcare-related pharmaceutical ingredients manufacturer within the broader Daewoong group.